Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In episode 2 of an ongoing series of sharing sessions between a physician and patient, Robert Gish, MD, FAASLD, and patient advocate, Alan Wang, discuss stigma as a barrier to optimal HBV care and treatment. The conversation focuses on how stigma affected Alan’s engagement with his care and strategies to overcome stigma as a barrier to HBV care.
Robert Gish, MD, FAASLD
Hepatitis B Foundation
Asian Pacific Health Foundation
San Diego, California
Brief presentation by Dr. Anna Christina dela Cruz on the various methods to assess liver inflammation and fibrosis and translating results into practice from Clinical Care Options (CCO)
Download free slides reviewing key data and AASLD guidance on methods to evaluate liver fibrosis and inflammation in patients with HBV infection
W. Grace L. H. Wong 博士，来自 Clinical Care Options (CCO)的慢性 HBV 患者的 HCC 风险评估和跨学科管理
Clinical Care Options (CCO) expert commentary on incorporating family history into clinical decision-making when caring for patients with hepatitis B